<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Microbiology</journal-title></journal-title-group><issn pub-type="epub">1664-302X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5816047</article-id><article-id pub-id-type="doi">10.3389/fmicb.2018.00155</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Mini Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Rewriting the Metabolic Blueprint: Advances in Pathway Diversification in Microorganisms</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hossain</surname><given-names>Gazi Sakir</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/497555/overview"/></contrib><contrib contrib-type="author"><name><surname>Nadarajan</surname><given-names>Saravanan Prabhu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/522854/overview"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/497702/overview"/></contrib><contrib contrib-type="author"><name><surname>Ng</surname><given-names>Tee-Kheang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/497700/overview"/></contrib><contrib contrib-type="author"><name><surname>Foo</surname><given-names>Jee Loon</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/505366/overview"/></contrib><contrib contrib-type="author"><name><surname>Ling</surname><given-names>Hua</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/522831/overview"/></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Won Jae</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/524773/overview"/></contrib><contrib contrib-type="author"><name><surname>Chang</surname><given-names>Matthew Wook</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/138596/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore</institution>, <addr-line>Singapore</addr-line>, <country>Singapore</country></aff><aff id="aff2"><sup>2</sup><institution>NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), Life Sciences Institute, National University of Singapore</institution>, <addr-line>Singapore</addr-line>, <country>Singapore</country></aff><aff id="aff3"><sup>3</sup><institution>Agency for Science, Technology and Research (A<sup>&#x02217;</sup>STAR), Institute of Chemical and Engineering Sciences</institution>, <addr-line>Singapore</addr-line>, <country>Singapore</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: <italic>Ryan S. Senger, Virginia Tech, United States</italic></p></fn><fn fn-type="edited-by"><p>Reviewed by: <italic>Pablo Ivan Nikel, The Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain), Denmark; Yinjie Tang, Washington University in St. Louis, United States</italic></p></fn><corresp id="fn001">*Correspondence: <italic>Matthew Wook Chang, <email xlink:type="simple">matthew_chang@nuhs.edu.sg</email>; <email xlink:type="simple">bchcmw@nus.edu.sg</email></italic></corresp><fn fn-type="other" id="fn002"><p><sup>&#x02020;</sup>These authors have contributed equally to this work.</p></fn><fn fn-type="other" id="fn003"><p>This article was submitted to Microbial Physiology and Metabolism, a section of the journal Frontiers in Microbiology</p></fn></author-notes><pub-date pub-type="epub"><day>12</day><month>2</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><elocation-id>155</elocation-id><history><date date-type="received"><day>14</day><month>11</month><year>2017</year></date><date date-type="accepted"><day>23</day><month>1</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Hossain, Nadarajan, Zhang, Ng, Foo, Ling, Choi and Chang.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Hossain, Nadarajan, Zhang, Ng, Foo, Ling, Choi and Chang</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Living organisms have evolved over millions of years to fine tune their metabolism to create efficient pathways for producing metabolites necessary for their survival. Advancement in the field of synthetic biology has enabled the exploitation of these metabolic pathways for the production of desired compounds by creating microbial cell factories through metabolic engineering, thus providing sustainable routes to obtain value-added chemicals. Following the past success in metabolic engineering, there is increasing interest in diversifying natural metabolic pathways to construct non-natural biosynthesis routes, thereby creating possibilities for producing novel valuable compounds that are non-natural or without elucidated biosynthesis pathways. Thus, the range of chemicals that can be produced by biological systems can be expanded to meet the demands of industries for compounds such as plastic precursors and new antibiotics, most of which can only be obtained through chemical synthesis currently. Herein, we review and discuss novel strategies that have been developed to rewrite natural metabolic blueprints in a bid to broaden the chemical repertoire achievable in microorganisms. This review aims to provide insights on recent approaches taken to open new avenues for achieving biochemical production that are beyond currently available inventions.</p></abstract><kwd-group><kwd>metabolic engineering</kwd><kwd>synthetic biology</kwd><kwd>pathway engineering</kwd><kwd>protein engineering</kwd><kwd>biochemical production</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">National University of Singapore<named-content content-type="fundref-id">10.13039/501100001352</named-content></funding-source><award-id rid="cn001">DPRT/943/09/14</award-id></award-group><award-group><funding-source id="cn002">Ministry of Education - Singapore<named-content content-type="fundref-id">10.13039/501100001459</named-content></funding-source><award-id rid="cn002">MOE/2014/T2/2/128</award-id></award-group><award-group><funding-source id="cn003">National Research Foundation Singapore<named-content content-type="fundref-id">10.13039/501100001381</named-content></funding-source><award-id rid="cn003">SBP-P2</award-id></award-group><award-group><funding-source id="cn004">Ministry of Knowledge Economy<named-content content-type="fundref-id">10.13039/501100002994</named-content></funding-source><award-id rid="cn004">N0000677</award-id></award-group><award-group><funding-source id="cn005">National Research Foundation Singapore<named-content content-type="fundref-id">10.13039/501100001381</named-content></funding-source><award-id rid="cn005">ICP1600012</award-id></award-group></funding-group><counts><fig-count count="2"/><table-count count="1"/><equation-count count="0"/><ref-count count="67"/><page-count count="10"/><word-count count="0"/></counts></article-meta></front><body><sec><title>Introduction</title><p>Nature&#x02019;s strength and beauty come from its diversity in biochemical systems, which not only generate but also degrade essential and non-essential chemical substances in living single cells or multicellular organisms through different biochemical reactions (i.e., metabolic pathways) that collectively form cellular metabolism. Consequently, a diverse range of biochemicals are present in nature. Many of these biochemicals are secondary metabolites to the native organisms but are of high biotechnological value to industries (<xref rid="B41" ref-type="bibr">Oksman-Caldentey and Inze, 2004</xref>; <xref rid="B25" ref-type="bibr">Harvey, 2008</xref>; <xref rid="B11" ref-type="bibr">Dhakal et al., 2017</xref>). Characterization of these secondary metabolites and exploration of the metabolic networks involved can potentially enable sustainable production of valuable and useful chemicals (<xref rid="B41" ref-type="bibr">Oksman-Caldentey and Inze, 2004</xref>). Although metabolic engineering has enabled the bioproduction of many valuable chemicals and has realized the aim of industrial-scale bio-based manufacturing of important compounds (e.g., 1,3-propanediol and artemisinin) (<xref rid="B66" ref-type="bibr">Zhu and Jackson, 2015</xref>), the range of compounds that can be generated are generally limited to those that occur naturally in living systems and with known biosynthesis pathways. Furthermore, the array of value-added chemicals required by industries is highly varied and many of these compounds can only be chemically synthesized as they are non-natural, and hence beyond the biosynthesis capabilities of existing biological systems. For example, different metabolic architectures have been identified from various organisms to produce carboxylic acids, which are central compounds in cellular metabolism (<xref rid="B35" ref-type="bibr">Lid&#x000e9;n, 2017</xref>), thereby presenting promising sources for industrially important building blocks to manufacture bio-commodities, such as bioplastics. However, silicon-based materials can only be produced chemically because of the absence of organosilicon molecules in living organisms (<xref rid="B2" ref-type="bibr">Apeloig et al., 2001</xref>). Likewise, important secondary metabolites, such as polyketides and alkaloids, isolated from organisms (e.g., plants and marine microorganisms) can provide alternative therapeutics against health threats such as multidrug resistance bacteria and intractable cancers (<xref rid="B10" ref-type="bibr">Dhakal et al., 2016</xref>). Yet, while more potent analogs of these natural products may be discovered and obtained chemically (<xref rid="B9" ref-type="bibr">DeChristopher et al., 2012</xref>), novel biosynthesis routes to these superior non-natural drugs are elusive. Thus, it is imperative to diversify natural metabolic pathways to conceive novel ones that are capable of producing any desirable chemical through biological means. Herein, we will review novel strategies for rewriting natural metabolic blueprints and designing of biosynthetic pathways with computational tools (<bold>Figures <xref ref-type="fig" rid="F1">1</xref></bold>, <bold><xref ref-type="fig" rid="F2">2</xref></bold> and <bold>Table <xref ref-type="table" rid="T1">1</xref></bold>). We aim to provide current insights and future perspectives on how progress in the state-of-the-art approaches in metabolic pathway diversification for the production of novel value-added compounds will eventually facilitate the development of efficient designer microorganisms that can potentially meet most of the chemical needs of modern civilization.</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Overview of strategies employed for diversification of metabolic pathways to produce value-added compounds in microorganisms.</p></caption><graphic xlink:href="fmicb-09-00155-g001"/></fig><fig id="F2" position="float"><label>FIGURE 2</label><caption><p>Illustration of distinct examples for each diversification approach.</p></caption><graphic xlink:href="fmicb-09-00155-g002"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Examples of notable novel valuable compounds produced in microbial cell factories through diversification of metabolic pathways and computational tools developed for pathway design.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Products</th><th valign="top" align="left" rowspan="1" colspan="1">Details of strategy</th><th valign="top" align="left" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td valign="top" align="left" colspan="3" rowspan="1"><bold>Rewriting metabolic blueprint with natural enzyme</bold></td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1"><hr/></td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1"><bold>Gap-filling of pathways</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Nargenicin A1</td><td valign="top" align="left" rowspan="1" colspan="1">Novel analog of nargenicin A1 was produced by expression of hydroxylase PikC from <italic>Streptomyces venezuelae</italic>.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B10" ref-type="bibr">Dhakal et al., 2016</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Odd-chain fatty alcohol</td><td valign="top" align="left" rowspan="1" colspan="1">Plant-derived &#x003b1;-dioxygenase enabled odd-chain length fatty aldehyde production from even chain fatty acid, further reduction led to formation of odd-chain fatty alcohol.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B29" ref-type="bibr">Jin et al., 2016</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Long chain dicarboxylic acid</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Pseudomonas</italic>-derived Baeyer&#x02013;Villiger monooxygenase enzyme enabled production of dicarboxylic acid.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B47" ref-type="bibr">Song et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Salvianic acid A</td><td valign="top" align="left" rowspan="1" colspan="1">Metabolic engineering of <italic>Escherichia coli</italic> with <sc>D</sc>-lactate dehydrogenase achieved salvianic acid A production.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B61" ref-type="bibr">Yao et al., 2013</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2-Pyrrolidone</td><td valign="top" align="left" rowspan="1" colspan="1">Metabolic engineering of <italic>E. coli</italic> with 2-pyrrolidone synthase from <italic>Streptomyces azureus</italic> enabled 2-pyrrolidone production.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B64" ref-type="bibr">Zhang et al., 2016</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Biofuels</td><td valign="top" align="left" rowspan="1" colspan="1">Metabolic engineering of <italic>B. coagulans</italic> with citramalate synthase from <italic>Methanococcus jannaschii</italic> enabled synthesis of 2-ketoacid precursors.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B3" ref-type="bibr">Atsumi and Liao, 2008</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><sc>D</sc>-Lactic acid</td><td valign="top" align="left" rowspan="1" colspan="1">Synthesis of optically pure <sc>D</sc>-lactic acid was achieved in <italic>E. coli</italic> by expression of engineered glycerol dehydrogenase evolved for <sc>D</sc>-lactate dehydrogenase activity.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B55" ref-type="bibr">Wang et al., 2011</xref></td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1"><bold>Mix-and-matching of pathways</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Arbutin</td><td valign="top" align="left" rowspan="1" colspan="1">The skin-lightening agent was biosynthesized in <italic>E. coli</italic> by co-expressing 4-hydroxybenzoate 1-hydroxylase from <italic>Candida parapsilosis</italic> and arbutin synthase from <italic>Rauvolfia serpentina.</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B45" ref-type="bibr">Shen et al., 2017</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Polyketide analogs</td><td valign="top" align="left" rowspan="1" colspan="1">Matching the <sc>D</sc>-desosamine and <sc>L</sc>-mycarose deoxysugar pathways with the alternative <sc>D</sc>-mycaminose and <sc>D</sc>-olivose pathways to produce new erythromycin analogs through the <italic>E. coli</italic> heterologous system.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B28" ref-type="bibr">Jiang et al., 2013</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Opiates and related molecules</td><td valign="top" align="left" rowspan="1" colspan="1">Production of opiate in yeast was achieved through the combination of new enzyme discovery, enzyme modification, and metabolic pathway optimization. Mixing and matching of 44 enzymes from bacteria, yeast, plants, and mammals were required.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B19" ref-type="bibr">Galanie et al., 2015</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Phenylpropanoid derivatives</td><td valign="top" align="left" rowspan="1" colspan="1">Seven biosynthetic genes from plants and bacteria were mixed and matched in <italic>E. coli</italic> to produce phenylpropanoid acids, stilbenoids and curcuminoids.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B56" ref-type="bibr">Wang et al., 2015</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">4-Ketozeinoxanthin</td><td valign="top" align="left" rowspan="1" colspan="1">4-Ketozeinoxanthin was produced in <italic>E. coli</italic> by mixing and matching of carotenoid ketolase gene from marine bacteria, lycopene biosynthesis genes from soil bacterium <italic>Pantoea ananatis</italic> and lycopene &#x003b2;-cyclase, lycopene &#x1d700;-cyclase, &#x003b2;-carotenoid hydroxylase from liverwort <italic>Marchantia polymorpha</italic>.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B36" ref-type="bibr">Maoka et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Unnatural multi-methyl-branched butyl esters (MBEs)</td><td valign="top" align="left" rowspan="1" colspan="1">MBEs were produced by engineered <italic>E. coli</italic> where mycocerosic polyketide synthases (PKSs) were mixed and matched from <italic>Mycobacterium tuberculosis</italic>. Expression of those enzymes enabled the biosynthesis of MBEs by utilizing various lengths of fatty acid with linear and branched chain alcohols.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B38" ref-type="bibr">Menendez-Bravo et al., 2014</xref></td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1"><hr/></td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1"><bold>Rewriting metabolic blueprint with non-natural enzyme</bold></td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1"><hr/></td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1"><bold>Precursor-directed biosynthesis</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Polyketides</td><td valign="top" align="left" rowspan="1" colspan="1">Substrate promiscuity of crotonyl-CoA carboxylase/reductase (CCR) homologs enabled the production of unnatural polyketide derivatives.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B57" ref-type="bibr">Wilson and Moore, 2012</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Andrimid analog</td><td valign="top" align="left" rowspan="1" colspan="1">Precursor-directed evolved non-ribosomal peptide synthetase (NRPS) produced three derivatives of the antibacterial compound, andrimid, in the native producer, <italic>Pantoea agglomerans</italic>. The compounds were analogs of the natural product with diverse functionality.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B14" ref-type="bibr">Evans et al., 2011</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fluorinated polyketide</td><td valign="top" align="left" rowspan="1" colspan="1">Directed evolution-generated polyketide synthase enabled utilization of fluorinated building blocks to produce novel fluorinated scaffold of polyketide.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B51" ref-type="bibr">Walker et al., 2013</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Tetracycline analogs</td><td valign="top" align="left" rowspan="1" colspan="1">Novel tetracycline analogs with different scaffolds were produced using a new set of tailoring enzymes.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B54" ref-type="bibr">Wang et al., 2012</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Calcium dependent antibiotics</td><td valign="top" align="left" rowspan="1" colspan="1">Engineering the adenylation domain of NRPS enabled novel NRP production using non-natural amino acid as precursor.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B50" ref-type="bibr">Thirlway et al., 2012</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Nitro-substituted polyketide aureothin</td><td valign="top" align="left" rowspan="1" colspan="1">Rational design and directed evolution of aureothin modular polyketide synthase enabled diverse polyketide production.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B48" ref-type="bibr">Sugimoto et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Unnatural alkaloid scaffold</td><td valign="top" align="left" rowspan="1" colspan="1">Novel polyketide-alkaloid hybrid molecules were produced using precursor-directed and structure-based design.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B39" ref-type="bibr">Morita et al., 2011</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Erythromycin A analog</td><td valign="top" align="left" rowspan="1" colspan="1">Tailoring the enzymes of erythromycin gene cluster enabled benzoate to be used as a precursor leading to the formation of novel erythromycin derivative.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B63" ref-type="bibr">Zhang et al., 2010</xref>;<xref rid="B27" ref-type="bibr">Jiang and Pfeifer, 2013</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Clorobiocin analog</td><td valign="top" align="left" rowspan="1" colspan="1">3,4-Dihydroxybenzoic acid was produced <italic>de novo</italic> as precursor for the biosynthesis pathway of the antibiotic clorobiocin to generate a potent analog.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B1" ref-type="bibr">Alt et al., 2011</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Alkyne labeled polyketide</td><td valign="top" align="left" rowspan="1" colspan="1">Heterologous expression of a terminal alkyne-forming operon with PKS/NPRS genes in <italic>E. coli</italic> enabled alkyne-labeled polyketide production from hexenoic acid.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B67" ref-type="bibr">Zhu et al., 2015</xref></td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1"><bold>Evolution of natural enzymes for non-natural biochemical reactions</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2,4-DHB</td><td valign="top" align="left" rowspan="1" colspan="1">Novel products were produced by evolving enzymes in an aspartate-using pathway for previously unreported activities to create an analogous malate-utilizing pathway.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B53" ref-type="bibr">Walther et al., 2017</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cyclopropanes and olefin metathesis</td><td valign="top" align="left" rowspan="1" colspan="1">Engineered cytochrome P450 enabled selective carbene transfers from diazoesters to olefins for cyclopropanation.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B6" ref-type="bibr">Coelho et al., 2013</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sulfimides</td><td valign="top" align="left" rowspan="1" colspan="1">Evolved cytochrome P450 catalyzed imidation of sulfides to form sulfimides.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B15" ref-type="bibr">Farwell et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Aziridines</td><td valign="top" align="left" rowspan="1" colspan="1">Engineered cytochrome P450 achieved intermolecular aziridination using tosyl azide and styrenes as substrates.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B16" ref-type="bibr">Farwell et al., 2015</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Organoboranes</td><td valign="top" align="left" rowspan="1" colspan="1">Directed evolution of cytochrome c enabled synthesis of organoboranes.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B31" ref-type="bibr">Kan et al., 2017</xref></td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1"><hr/></td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1"><bold>Computational pathway design</bold></td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1"><hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">fastGapFill</td><td valign="top" align="left" rowspan="1" colspan="1">fastGapFill reconstructs metabolic networks by identifying enzyme candidates from universal reaction databases to gap-fill missing pathways.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B49" ref-type="bibr">Thiele et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BoostGAPFILL</td><td valign="top" align="left" rowspan="1" colspan="1">BoostGAPFILL predicts missing biochemical reactions in metabolic networks based on metabolites present, including non-native ones.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B42" ref-type="bibr">Oyetunde et al., 2017</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RetroPath</td><td valign="top" align="left" rowspan="1" colspan="1">RetroPath is a computation tool that automates metabolic pathway design for given sets of specifications, including precursors and target chemicals.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B5" ref-type="bibr">Carbonell et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pinocembrin</td><td valign="top" align="left" rowspan="1" colspan="1">A five-enzyme pathway was designed using RetroPath to successfully produce pinocembrin in <italic>E. coli</italic> from malonyl-CoA.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B17" ref-type="bibr">Feher et al., 2014</xref></td></tr></tbody></table></table-wrap></sec><sec><title>Strategies to Diversify Metabolic Pathway for Synthesis of Value-Added Compounds</title><p>In order to produce novel compounds biologically, it is essential to rewire the native metabolic pathways in production hosts to form new ones that will lead to the desired compounds. Non-natural biosynthesis routes need to be designed, implemented and optimized through metabolic engineering for efficient production of the target compounds. In this section, we will review efforts in production of value-added compounds accomplished through rewriting of metabolic network with natural and non-natural enzymes, as well as computational design of non-natural metabolic pathways.</p><sec><title>Rewriting the Metabolic Blueprint Using Natural Enzymes</title><p>Enzymes vary widely in the reactions they catalyze and in their substrate specificities. Homologs are present across different species thus there is a vast number of enzyme candidates that can be selected from nature for construction of novel pathways. By introducing non-native enzymes from different organisms into a production host, metabolic rewiring can be achieved to expand possibilities for biosynthesis of novel compounds. Two different approaches have been utilized to rewrite metabolic networks using natural enzymes: gap-filling and mix-and-matching of pathways. Here, we will review the employment of these strategies for diversifying metabolic pathways to produce value-added compounds.</p><sec><title>Gap-Filling of Pathways</title><p>Native metabolic pathways in organisms are connected and insulated from one another to varying degrees (<xref rid="B24" ref-type="bibr">Hartwell et al., 1999</xref>). By gap-filling pathways with heterologous enzymes, shunts can be built between the pathways to create new and diverse biosynthesis routes toward desired metabolites (<xref rid="B46" ref-type="bibr">Shin et al., 2013</xref>; <xref rid="B34" ref-type="bibr">Lee and Kim, 2015</xref>). Essentially, by introducing a suitable non-native enzyme, a metabolite from a native pathway can be converted by the heterologous enzyme to a non-native intermediate to serve as a substrate of a previously disconnected native pathway, thus creating a novel biosynthesis pathway for producing target compounds. For example, the biosynthesis of odd-chain fatty alcohols, which is of industrial value, is made possible by the heterologous expression of &#x003b1;-dioxygenase from <italic>Oryza sativa</italic> in <italic>Saccharomyces cerevisiae</italic> (<xref rid="B29" ref-type="bibr">Jin et al., 2016</xref>). The &#x003b1;-dioxygenase can convert endogenous even-chain fatty acids to odd-chain fatty aldehydes which are subsequently reduced by native alcohol dehydrogenases to produce odd-chain fatty alcohols (<xref rid="B29" ref-type="bibr">Jin et al., 2016</xref>). Notably, although the biosynthesis pathway of salvianic acid A in the plant <italic>Salvia miltiorrhiza</italic> was unclear, the therapeutic antioxidant was remarkably produced in <italic>Escherichia coli</italic> by rerouting endogenously produced 4-hydroxyphenylpyruvate with <sc>D</sc>-lactate dehydrogenase derived from <italic>Lactobacillus pentosus</italic> to 4-hydroxyphenyllactate for conversion by a native hydroxylase complex to salvianic acid A (<xref rid="B60" ref-type="bibr">Yao et al., 2015</xref>). Similarly, novel nargenicin A1 derivatives were synthesized in <italic>Nocardia</italic> by introducing a hydroxylase (PikC) derived from the pikromycin gene cluster of <italic>Streptomyces venezuelae</italic> (<xref rid="B10" ref-type="bibr">Dhakal et al., 2016</xref>). The gap-filling strategy was also employed for the efficient synthesis of optically pure <sc>D</sc>-lactic acid in high titers by utilizing a glycerol dehydrogenase engineered for <sc>D</sc>-lactate dehydrogenase activity to gap-fill the pyruvate metabolism in <italic>Bacillus coagulans</italic> (<xref rid="B55" ref-type="bibr">Wang et al., 2011</xref>). Likewise, to produce biofuels such as propanol and butanol in high yield, a new pathway was engineered in <italic>E. coli</italic> for the production of 2-ketoacid precursors from pyruvate and acetyl-CoA by utilizing citramalate synthase from <italic>Methanococcus jannaschii</italic> (<xref rid="B3" ref-type="bibr">Atsumi and Liao, 2008</xref>). Other notable value-added chemicals produced by the gap-filling strategy, such as long-chain dicarboxylic acid (<xref rid="B47" ref-type="bibr">Song et al., 2014</xref>) and 2-pyrrolidone (<xref rid="B64" ref-type="bibr">Zhang et al., 2016</xref>), are summarized in <bold>Table <xref ref-type="table" rid="T1">1</xref></bold>. These examples illustrate that although gap-filling is a simple approach, relying on expression of a heterologous enzyme to diversify metabolic pathways, it demonstrates great potential in expanding the range of bio-based chemicals that can be produced. However, a major disadvantage of the gap-filling strategy is that it is applicable only when an intermediate metabolite can be found that links two native pathways to produce the target compound, thus limiting the possibilities of attainable pathway diversification. To allow greater diversification of biosynthetic pathways, rewiring of metabolic networks needs to be more extensive using other strategies such as mix-and-matching of pathways.</p></sec><sec><title>Mix-and-Matching of Pathways</title><p>The mix-and-match approach combinatorically expresses multiple genes or clusters from numerous organisms in a production host to produce metabolites of interest (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>). Given the large number of annotated enzymes with known functions, artificial biosynthesis routes can therefore be built rationally by mix-and-matching suitable non-native enzymes to diversify native pathways toward target compounds. This strategy is particularly useful for reconstruction of pathways that are not fully elucidated and is exemplified by the production of the skin lightening agent arbutin in <italic>E. coli</italic>. Although the natural pathway for biosynthesizing arbutin is not fully understood, it was successfully produced in <italic>E. coli</italic> by diversifying the chorismic acid metabolic pathway with 4-hydroxybenzoate 1-hydroxylase from <italic>Candida parapsilosis</italic> to produce hydroquinone, which serves as the substrate for arbutin synthase from <italic>Rauvolfia serpentina</italic> to produce arbutin (<xref rid="B45" ref-type="bibr">Shen et al., 2017</xref>). The mix-and-match approach is also an effective strategy for producing variants of natural products, such as polyketides, carotenoids, phenyl propanoids and alkaloids, which involve gene clusters for biosynthesis. Genes in diverse sets of homologous gene clusters from different organisms can be viewed as &#x0201c;modules&#x0201d; for combinatorial assembly to produce novel derivatives. Using this strategy, novel pathways were constructed to enable biosynthesis of compounds with therapeutic and commercial value (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>). Taken together, the mix-and-match approach has demonstrated immense potential for diversifying metabolic pathways using combinations of natural enzymes for the production of novel value-added compounds. Nevertheless, mix-and-matching of pathways is often marred by low productivity due to substrate specificity constraints since the new metabolites are not natural substrates of the enzymes in the pathways assembled. Thus, the full potential of the mix-and-match strategy could only be realized by involving non-natural enzymes that have been evolved to suit the needs of the novel pathways.</p></sec></sec><sec><title>Rewriting the Metabolic Blueprint with Non-natural Enzyme</title><p>Diversification of natural metabolic pathways to create novel biosynthesis routes will inevitably form intermediate metabolites that are beyond the substrate range which the natural enzymes involved can perform efficiently. Although nature has provided us with a gamut of enzymes to choose from, generation of non-natural enzymes is often essential for successful construction of efficient novel pathways to extensively rewrite metabolic blueprints (<xref rid="B18" ref-type="bibr">Foo et al., 2012</xref>). As most natural enzymes exhibit degrees of substrate promiscuity to analogs of their natural substrates (<xref rid="B23" ref-type="bibr">Gupta, 2016</xref>), promiscuous properties of natural enzymes can be exploited through protein engineering approaches to evolve their activities toward non-natural substrates. In addition to employment in gap-filling and mix-and-matching of pathways, non-natural enzymes have important applications for precursor-directed biosynthesis and catalysis of non-natural biochemical reactions, which are powerful strategies that we will review in this section for bio-based production of novel value-added chemicals.</p><sec><title>Precursor-Directed Biosynthesis</title><p>Precursor-directed biosynthesis involves using evolved enzymes with altered substrate specificity to incorporate structurally diverse analogs of natural substrates into novel metabolic pathways in order to produce non-natural biochemicals. Commonly, substrate analogs are provided <italic>ex vivo</italic> to production hosts with non-natural enzymes with relaxed substrate specificity to form novel intermediates. While it is possible to rely on substrate promiscuity of the natural enzymes in the native pathways to convert the intermediates to the desired natural product derivatives, engineered enzymes are frequently required for the pathways to be efficient. For example, acyltransferase, the &#x0201c;gatekeeping&#x0201d; enzyme to polyketide synthesis, has been engineered to accept analogs of natural acyl-CoA precursors to initiate production of novel polyketide derivatives (<xref rid="B12" ref-type="bibr">Dunn and Khosla, 2013</xref>). Inclusion of enzymes modified by protein engineering in the downstream pathway can greatly facilitate the conversion of the resulting non-natural intermediates to a wide range of polyketide derivatives with potential therapeutic properties, as exemplified by the work of <xref rid="B33" ref-type="bibr">Lee et al. (2011)</xref> to create derivatives of the antibiotic erythromycin. Similar approaches were applied to enable biosynthesis of a wide range of novel derivatives of polyketides, non-ribosomal peptides (NRPs) and phenyl propanoids (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>). <italic>De novo</italic> precursor-directed biosynthesis can be achieved by co-expressing a pathway for generating substrate analog <italic>in vivo</italic> instead of <italic>ex vivo</italic> supplementation. This was demonstrated by Alt et al. for producing a novel derivative of the antibiotic clorobiocin by employing a 3,4-dihydroxybenzoic acid-producing pathway to provide the non-natural precursor to the clorobiocin biosynthesis pathway, resulting in the production of a potent DNA gyrase inhibitor (<xref rid="B1" ref-type="bibr">Alt et al., 2011</xref>).</p><p>With these examples, precursor-directed biosynthesis has proven to be an effective approach for generating a wide array of novel compounds rapidly with non-natural precursors. However, these precursors are often expensive and could only be synthesized chemically. Therefore, generating enzymes that can catalyze non-natural reactions are vital for progressing diversification of metabolic pathways.</p></sec><sec><title>Evolution of Natural Enzymes for Non-natural Biochemical Reactions</title><p>Metabolic engineering has advanced by leaps and bounds over the past decades facilitating the biosynthesis of many valuable compounds for pharmaceutical and industrial applications. However, chemical synthesis still has an edge in terms of the versatility of chemical structures that can be generated because biological synthesis is limited by the number of natural enzymes available (<xref rid="B52" ref-type="bibr">Wallace and Balskus, 2014</xref>). To circumvent this constraint, efforts have been directed toward creating enzymes that can perform reactions that have not been possible biologically for constructing novel metabolic pathways to produce compounds without known natural biosynthesis routes. For example, the versatile chemical, 2,4-dihydroxybutyric acid (2,4-DHB), was produced by exploiting a natural metabolic pathway involving aspartate to utilize malate, a structurally similar analog, as precursor (<xref rid="B53" ref-type="bibr">Walther et al., 2017</xref>). By engineering the enzymes in the natural pathway, novel enzymes with previously unreported activities in nature, namely malate semialdehyde reductase, malate kinase, and malate semialdehyde dehydrogenase, were generated to create an artificial 2,4-DHB-producing pathway. This illustrates the importance of non-natural enzymes for diversifying metabolic pathways. In recent years, numerous evolution and engineering strategies were applied to mechanistically diverse the superfamilies of biocatalysts to perform novel reactions (<xref rid="B22" ref-type="bibr">Gerlt and Babbitt, 2009</xref>). For instance, cytochrome P450s have been evolved to perform olefin aziridination (<xref rid="B16" ref-type="bibr">Farwell et al., 2015</xref>), carbene transfer to olefin (<xref rid="B6" ref-type="bibr">Coelho et al., 2013</xref>), and imidation of sulfides (<xref rid="B15" ref-type="bibr">Farwell et al., 2014</xref>), reactions which are unknown in the biological world. The promising trend of growing number of novel enzymes catalyzing non-natural biochemical reactions suggest the possibility of constructing fully artificial pathways to biosynthesize any compound that can be accomplished chemically.</p></sec></sec><sec><title>Computational Pathway Design</title><p>As computing power grew exponentially in the past decade, computational tools became increasingly attractive as toolkits for metabolic engineering. While these tools initially were employed mainly to optimize metabolic pathways for achieving production of target compound with high yield (<xref rid="B7" ref-type="bibr">Copeland et al., 2012</xref>), they have been extended to facilitate designing of novel pathways. For example, to complement a rapid increase in the number of sequenced genomes, computational methods were created for data mining to identify and annotate genes (<xref rid="B4" ref-type="bibr">Blanco and Abril, 2009</xref>). However, it has reached a stage where the data generated exceeds the rate that they can be sifted and organized (<xref rid="B32" ref-type="bibr">Khosla, 2015</xref>). Automated annotation of these &#x0201c;big data&#x0201d; simply based on sequence homology has been unreliable or unsuccessful half of the time (<xref rid="B20" ref-type="bibr">Gerlt, 2016</xref>). To understand relationships between proteins in the databases, the &#x0201c;big data&#x0201d; generated could greatly benefit from tools developed by the Enzyme Function Initiative, such as EFI-EST and EFI-GNT (<xref rid="B21" ref-type="bibr">Gerlt, 2017</xref>), which use multidisciplinary approaches to accurately assign enzyme functions (<xref rid="B20" ref-type="bibr">Gerlt, 2016</xref>). Proper functional assignment is vital for identifying novel enzyme candidates from diverse superfamilies that can be deployed to construct non-natural biosynthesis routes. However, for diversification of metabolic pathways, creation of tools to predict and identify plausible routes are imperative to accelerate the design process for integrating heterologous genes to produce novel compounds in defined hosts. Therefore, computational tools such as BoostGAPFILL (<xref rid="B42" ref-type="bibr">Oyetunde et al., 2017</xref>) and fastGapFill (<xref rid="B49" ref-type="bibr">Thiele et al., 2014</xref>) have been developed to enable identification of candidate enzymes from a universal biochemical reaction database to fill network gaps. To enable the design of biologically feasible pathways to produce any target compound of interest, the retrosynthesis approach, which is a well-established method used in organic chemistry for identifying suitable precursors and synthesis routes, was combined with biological knowledge to create tools such as RetroPath (<xref rid="B5" ref-type="bibr">Carbonell et al., 2014</xref>) to automate the pathway design process. Several possible pathways consisting of various enzymes that can lead precursors to the target compound can be proposed and ranked based on selected criteria. Subsequently, RetroPath was successfully applied to design a pathway for biosynthesizing the antioxidant flavonoid pinocembrin, resulting in a five-enzyme pathway starting from malonyl-CoA as precursor (<xref rid="B17" ref-type="bibr">Feher et al., 2014</xref>). These promising computational tools and results suggest that computational pathway design will greatly facilitate the design of novel pathways and continued efforts in improving these computational suites will enable expansion of the chemical repertoire that can be produced biologically.</p></sec></sec><sec><title>Conclusion and Future Perspectives</title><p>Metabolic engineering has progressed tremendously over decades with the aim to efficiently produce biochemicals from renewable resources to serve industrial needs. Indeed, there are many examples of engineered microbes that are able to produce industrially relevant levels of biochemical for commercialization (<xref rid="B66" ref-type="bibr">Zhu and Jackson, 2015</xref>). However, metabolic engineering is still largely limited to production of chemicals that exist naturally in biological systems. Therefore, the range of chemicals that metabolic engineering can generate is unable to meet that required by industries. Consequently, there is still heavy reliance on chemical synthesis from fossil resources for precursors needed by industries (<xref rid="B52" ref-type="bibr">Wallace and Balskus, 2014</xref>). Hence, diversification of metabolic pathways is crucial to achieve biosynthesis of non-natural compounds to rival the capabilities of chemical synthesis. Herein, we have reviewed several strategies that have been developed in the attempt to broaden the spectrum of compounds that can be created biologically. While the results have been promising, much still needs to be done before biological systems can be utilized to produce any target compound of choice.</p><p>Being a well-established field on its own, protein engineering is an area that can greatly benefit and complement efforts in metabolic pathway diversification (<xref rid="B18" ref-type="bibr">Foo et al., 2012</xref>). By increasing the number of available biocatalysts to catalyze non-natural reactions, protein engineering tools act as a driving force for designing new biosynthesis routes to create novel compounds. Further, these tailor-made enzymes catalyzing novel non-natural reactions uncover new arena to establish novel metabolic pathways. One remarkable example of the capability of protein engineering is the evolution of a natural enzyme to create carbon-silicon bonds, which are important moieties in many commercial products but do not exist in nature, essentially opening up possibilities of creating silicon-based biosynthetic pathways (<xref rid="B30" ref-type="bibr">Kan et al., 2016</xref>). Likewise, evolved <italic>Rhodothermus marinus</italic> cytochrome <italic>c</italic> have been employed to enable carbon&#x02013;boron bond formation in <italic>E. coli</italic> to produce organoboranes, a class of compounds that are not found in biological systems but with applications in chemotherapeutics (<xref rid="B31" ref-type="bibr">Kan et al., 2017</xref>). With rapid advances in genome sequencing techniques, more enzymes will be identified to serve as candidates for engineering non-natural biochemical reactions. This may be complemented by the recent boom in microbiome studies, where metagenomics techniques have been developed and applied to sequence genomes of many microorganisms that were previously uncultivable. Computation-guided genome mining can thus be applied to discover novel natural products and their biosynthetic pathways (<xref rid="B37" ref-type="bibr">Medema and Fischbach, 2015</xref>).</p><p>Ultimately, biosynthesis pathways are a series of synchronized chemical reactions performed in biological chassis. Therefore, to create diverse non-natural metabolic pathways, it is imperative to incorporate chemical knowledge and techniques, particularly retrosynthesis, to complement our understanding of biological systems when designing biochemical routes required to produce novel target compounds. As discussed earlier, combining computational tools with retrosynthesis has already achieved some success in designing non-natural pathways for the biosynthesis of novel value-added compounds (<xref rid="B17" ref-type="bibr">Feher et al., 2014</xref>). By further developing user-friendly computational tools and databases that include all known natural and non-natural enzymes, automated platforms that integrate current strategies and knowledge pertinent to pathway diversification could be established to significantly accelerate designing and implementation of novel pathways.</p><p>Despite rapid advancement in the field of metabolic engineering and the potential tools available for interplaying with genetic material and metabolic networks of microbial workhorses, there are major bottlenecks that require resolution when forward engineering metabolic pathways. Alterations to metabolic pathways with heterologous or engineered enzymes in microbial hosts burden the microbial host and cause issues such as imbalance in metabolic pathways, poor growth, accumulation of toxic intermediates and other physiological stresses. Moreover, conventional model strains commonly used as production hosts often face issues under the harsh operating conditions of downstream industrial processes. These problems may be overcome by selecting suitable production hosts beyond the conventional ones, depending on the target compounds (<xref rid="B8" ref-type="bibr">Czajka et al., 2017</xref>). For example, the non-conventional oleaginous yeast <italic>Yarrowia lipolytica</italic> was exploited for production of fatty acid-derivatives (<xref rid="B66" ref-type="bibr">Zhu and Jackson, 2015</xref>). Furthermore, <italic>Pseudomonas</italic> strains possess metabolic, physiological and stress-tolerance characteristics that are favorable for metabolic engineering (<xref rid="B40" ref-type="bibr">Nikel et al., 2014</xref>) and <italic>Pseudomonas putida</italic> was demonstrated to be an ideal host for production of <italic>para</italic>-hydroxybenzoic acid due to its exceptional tolerance for aromatic compounds (<xref rid="B62" ref-type="bibr">Yu et al., 2016</xref>). In addition to strategic selection of production host, computation-guided pathway designing approaches, such as genome scale modeling and novel machine learning methods, have proven to be alternative solutions to solve metabolic imbalance issues by efficient strain engineering strategies (<xref rid="B58" ref-type="bibr">Wu G. et al., 2016</xref>; <xref rid="B59" ref-type="bibr">Wu S.G. et al., 2016</xref>). Concurrently, the lack of natural enzyme reaction cascade in engineered pathways brings about inefficient substrate conversion. To address this issue, artificial enzyme channels have been constructed to organize enzymes for efficient production of target compounds. This strategy has been reviewed extensively in literature (<xref rid="B44" ref-type="bibr">Proschel et al., 2015</xref>). These examples demonstrate that extensive efforts are ongoing for strain development to implement synthetic pathways efficiently, which is immensely beneficial for pathway diversification.</p><p>In conclusion, much progress in diversification of metabolic pathways has been made and the future for production of non-natural chemicals using biological systems is promising. There are fundamental concerns regarding the compatibility of non-natural pathways and products with living systems, such as substrate availability, toxicity of substrates and products, availability and intracellular balance of cofactors, and influx/efflux of substrates and products, that will impede the yield and productivity of the biosynthesis routes. Nevertheless, there are many tools available for strain engineering, such as targeted multi-site CRISPR/Cas9-based gene insertion or deletion (<xref rid="B26" ref-type="bibr">Jakociunas et al., 2015</xref>), riboswitch-based self-directed evolution of phenotype (<xref rid="B43" ref-type="bibr">Pham et al., 2017</xref>) and Synthetic Chromosome Recombination and Modification by LoxP-mediated Evolution (SCRaMbLE) in Synthetic Yeast 2.0 (<xref rid="B13" ref-type="bibr">Dymond and Boeke, 2012</xref>), that may be utilized to optimize host strains for tolerance towards non-natural pathways and products. Impressively, synthetic biology recently enabled the creation of a semi-synthetic organism to possess two additional letters in its codons that form an unnatural base pair. The organism can thus store increased genetic information and potentially create enzymes with novel activities, e.g., by incorporating non-canonical amino acids, thereby facilitate diversification of metabolic pathways (<xref rid="B65" ref-type="bibr">Zhang et al., 2017</xref>). In future, intensive research in pathway diversification might enable development of highly efficient microbial strains that can potentially carry out desired chemical reactions to produce any target compounds and eventually serve as a sustainable source for supplying valuable biochemicals to meet industrial needs.</p></sec><sec><title>Author Contributions</title><p>JLF, HL, WJC, and MWC conceptualized the content, figures, and table of the review. GSH, SPN, and LZ wrote the manuscript. JLF and HL revised the manuscript. T-KN and MWC proof corrected and reviewed the manuscript.</p></sec><sec><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was funded by the Synthetic Biology Initiative of the National University of Singapore (DPRT/943/09/14), the Ministry of Education, Singapore (MOE/2014/T2/2/128), Global R&#x00026;D Project Program, the Ministry of Knowledge Economy, the Republic of Korea (N0000677), and Synthetic Biology R&#x00026;D Programme (SBP-P2) and Industry Alignment Fund-Industry Collaboration Project (ICP1600012) of the National Research Foundation, Singapore.</p></fn></fn-group><ack><p>We thank Dr. Ping Han for her comments on the manuscript.</p></ack><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alt</surname><given-names>S.</given-names></name><name><surname>Burkard</surname><given-names>N.</given-names></name><name><surname>Kulik</surname><given-names>A.</given-names></name><name><surname>Grond</surname><given-names>S.</given-names></name><name><surname>Heide</surname><given-names>L.</given-names></name></person-group> (<year>2011</year>). <article-title>An artificial pathway to 3,4-dihydroxybenzoic acid allows generation of new aminocoumarin antibiotic recognized by catechol transporters of <italic>E. coli</italic>.</article-title>
<source><italic>Chem. Biol.</italic></source>
<volume>18</volume>
<fpage>304</fpage>&#x02013;<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2010.12.016</pub-id>
<?supplied-pmid 21439475?><pub-id pub-id-type="pmid">21439475</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Apeloig</surname><given-names>Y.</given-names></name><name><surname>Rappoport</surname><given-names>Z.</given-names></name><collab>John Wiley and Sons</collab></person-group> (eds). (<year>2001</year>). <article-title>&#x0201c;The chemistry of organic silicon compounds,&#x0201d; in</article-title>
<source><italic>The Chemistry of Functional Groups Supplement Si</italic></source>
<volume>Vol. 3</volume> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Wiley</publisher-name>).</mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atsumi</surname><given-names>S.</given-names></name><name><surname>Liao</surname><given-names>J. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Directed evolution of <italic>Methanococcus jannaschii</italic> citramalate synthase for biosynthesis of 1-propanol and 1-butanol by <italic>Escherichia coli</italic>.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>74</volume>
<fpage>7802</fpage>&#x02013;<lpage>7808</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.02046-08</pub-id>
<?supplied-pmid 18952866?><pub-id pub-id-type="pmid">18952866</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname><given-names>E.</given-names></name><name><surname>Abril</surname><given-names>J. F.</given-names></name></person-group> (<year>2009</year>). <article-title>Computational gene annotation in new genome assemblies using GeneID.</article-title>
<source><italic>Methods Mol. Biol.</italic></source>
<volume>537</volume>
<fpage>243</fpage>&#x02013;<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-59745-251-9_12</pub-id>
<?supplied-pmid 19378148?><pub-id pub-id-type="pmid">19378148</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carbonell</surname><given-names>P.</given-names></name><name><surname>Parutto</surname><given-names>P.</given-names></name><name><surname>Baudier</surname><given-names>C.</given-names></name><name><surname>Junot</surname><given-names>C.</given-names></name><name><surname>Faulon</surname><given-names>J. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Retropath: automated pipeline for embedded metabolic circuits.</article-title>
<source><italic>ACS Synth. Biol.</italic></source>
<volume>3</volume>
<fpage>565</fpage>&#x02013;<lpage>577</lpage>. <pub-id pub-id-type="doi">10.1021/sb4001273</pub-id>
<?supplied-pmid 24131345?><pub-id pub-id-type="pmid">24131345</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coelho</surname><given-names>P. S.</given-names></name><name><surname>Wang</surname><given-names>Z. J.</given-names></name><name><surname>Ener</surname><given-names>M. E.</given-names></name><name><surname>Baril</surname><given-names>S. A.</given-names></name><name><surname>Kannan</surname><given-names>A.</given-names></name><name><surname>Arnold</surname><given-names>F. H.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>A serine-substituted P450 catalyzes highly efficient carbene transfer to olefins <italic>in vivo</italic>.</article-title>
<source><italic>Nat. Chem. Biol.</italic></source>
<volume>9</volume>
<fpage>485</fpage>&#x02013;<lpage>487</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1278</pub-id>
<?supplied-pmid 23792734?><pub-id pub-id-type="pmid">23792734</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Copeland</surname><given-names>W. B.</given-names></name><name><surname>Bartley</surname><given-names>B. A.</given-names></name><name><surname>Chandran</surname><given-names>D.</given-names></name><name><surname>Galdzicki</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>K. H.</given-names></name><name><surname>Sleight</surname><given-names>S. C.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Computational tools for metabolic engineering.</article-title>
<source><italic>Metab. Eng.</italic></source>
<volume>14</volume>
<fpage>270</fpage>&#x02013;<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymben.2012.03.001</pub-id><pub-id pub-id-type="pmid">22629572</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czajka</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>Y. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Synthetic biology for manufacturing chemicals: constraints drive the use of non-conventional microbial platforms.</article-title>
<source><italic>Appl. Microbiol. Biotechnol.</italic></source>
<volume>101</volume>
<fpage>7427</fpage>&#x02013;<lpage>7434</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-017-8489-9</pub-id>
<?supplied-pmid 28884354?><pub-id pub-id-type="pmid">28884354</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeChristopher</surname><given-names>B. A.</given-names></name><name><surname>Loy</surname><given-names>B. A.</given-names></name><name><surname>Marsden</surname><given-names>M. D.</given-names></name><name><surname>Schrier</surname><given-names>A. J.</given-names></name><name><surname>Zack</surname><given-names>J. A.</given-names></name><name><surname>Wender</surname><given-names>P. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs <italic>in vitro</italic>.</article-title>
<source><italic>Nat. Chem.</italic></source>
<volume>4</volume>
<fpage>705</fpage>&#x02013;<lpage>710</lpage>. <pub-id pub-id-type="doi">10.1038/nchem.1395</pub-id>
<?supplied-pmid 22914190?><pub-id pub-id-type="pmid">22914190</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhakal</surname><given-names>D.</given-names></name><name><surname>Chaudhary</surname><given-names>A. K.</given-names></name><name><surname>Yi</surname><given-names>J. S.</given-names></name><name><surname>Pokhrel</surname><given-names>A. R.</given-names></name><name><surname>Shrestha</surname><given-names>B.</given-names></name><name><surname>Parajuli</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Enhanced production of nargenicin A1 and creation of a novel derivative using a synthetic biology platform.</article-title>
<source><italic>Appl. Microbiol. Biotechnol.</italic></source>
<volume>100</volume>
<fpage>9917</fpage>&#x02013;<lpage>9931</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-016-7705-3</pub-id>
<?supplied-pmid 27412463?><pub-id pub-id-type="pmid">27412463</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhakal</surname><given-names>D.</given-names></name><name><surname>Pokhrel</surname><given-names>A. R.</given-names></name><name><surname>Shrestha</surname><given-names>B.</given-names></name><name><surname>Sohng</surname><given-names>J. K.</given-names></name></person-group> (<year>2017</year>). <article-title>Marine rare Actinobacteria: isolation, characterization, and strategies for harnessing bioactive compounds.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>8</volume>:<issue>1106</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2017.01106</pub-id>
<?supplied-pmid 28663748?><pub-id pub-id-type="pmid">28663748</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>B. J.</given-names></name><name><surname>Khosla</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Engineering the acyltransferase substrate specificity of assembly line polyketide synthases.</article-title>
<source><italic>J. R. Soc. Interface</italic></source>
<volume>10</volume>:<issue>20130297</issue>. <pub-id pub-id-type="doi">10.1098/rsif.2013.0297</pub-id>
<?supplied-pmid 23720536?><pub-id pub-id-type="pmid">23720536</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dymond</surname><given-names>J.</given-names></name><name><surname>Boeke</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>The <italic>Saccharomyces cerevisiae</italic> SCRaMbLE system and genome minimization.</article-title>
<source><italic>Bioeng. Bugs</italic></source>
<volume>3</volume>
<fpage>168</fpage>&#x02013;<lpage>171</lpage>. <pub-id pub-id-type="doi">10.4161/bbug.19543</pub-id>
<?supplied-pmid 22572789?><pub-id pub-id-type="pmid">22572789</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>B. S.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Metcalf</surname><given-names>W. W.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Kelleher</surname><given-names>N. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Directed evolution of the nonribosomal peptide synthetase AdmK generates new andrimid derivatives <italic>in vivo</italic>.</article-title>
<source><italic>Chem. Biol.</italic></source>
<volume>18</volume>
<fpage>601</fpage>&#x02013;<lpage>607</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2011.03.008</pub-id>
<?supplied-pmid 21609841?><pub-id pub-id-type="pmid">21609841</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farwell</surname><given-names>C. C.</given-names></name><name><surname>McIntosh</surname><given-names>J. A.</given-names></name><name><surname>Hyster</surname><given-names>T. K.</given-names></name><name><surname>Wang</surname><given-names>Z. J.</given-names></name><name><surname>Arnold</surname><given-names>F. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Enantioselective imidation of sulfides via enzyme-catalyzed intermolecular nitrogen-atom transfer.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>136</volume>
<fpage>8766</fpage>&#x02013;<lpage>8771</lpage>. <pub-id pub-id-type="doi">10.1021/ja503593n</pub-id>
<?supplied-pmid 24901646?><pub-id pub-id-type="pmid">24901646</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farwell</surname><given-names>C. C.</given-names></name><name><surname>Zhang</surname><given-names>R. K.</given-names></name><name><surname>McIntosh</surname><given-names>J. A.</given-names></name><name><surname>Hyster</surname><given-names>T. K.</given-names></name><name><surname>Arnold</surname><given-names>F. H.</given-names></name></person-group> (<year>2015</year>). <article-title>Enantioselective enzyme-catalyzed aziridination enabled by active-site evolution of a cytochrome P450.</article-title>
<source><italic>ACS Cent. Sci.</italic></source>
<volume>1</volume>
<fpage>89</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.5b00056</pub-id>
<?supplied-pmid 26405689?><pub-id pub-id-type="pmid">26405689</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feher</surname><given-names>T.</given-names></name><name><surname>Planson</surname><given-names>A. G.</given-names></name><name><surname>Carbonell</surname><given-names>P.</given-names></name><name><surname>Fernandez-Castane</surname><given-names>A.</given-names></name><name><surname>Grigoras</surname><given-names>I.</given-names></name><name><surname>Dariy</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Validation of RetroPath, a computer-aided design tool for metabolic pathway engineering.</article-title>
<source><italic>Biotechnol. J.</italic></source>
<volume>9</volume>
<fpage>1446</fpage>&#x02013;<lpage>1457</lpage>. <pub-id pub-id-type="doi">10.1002/biot.201400055</pub-id>
<?supplied-pmid 25224453?><pub-id pub-id-type="pmid">25224453</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foo</surname><given-names>J. L.</given-names></name><name><surname>Ching</surname><given-names>C. B.</given-names></name><name><surname>Chang</surname><given-names>M. W.</given-names></name><name><surname>Leong</surname><given-names>S. S.</given-names></name></person-group> (<year>2012</year>). <article-title>The imminent role of protein engineering in synthetic biology.</article-title>
<source><italic>Biotechnol. Adv.</italic></source>
<volume>30</volume>
<fpage>541</fpage>&#x02013;<lpage>549</lpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2011.09.008</pub-id>
<?supplied-pmid 21963685?><pub-id pub-id-type="pmid">21963685</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galanie</surname><given-names>S.</given-names></name><name><surname>Thodey</surname><given-names>K.</given-names></name><name><surname>Trenchard</surname><given-names>I. J.</given-names></name><name><surname>Filsinger Interrante</surname><given-names>M.</given-names></name><name><surname>Smolke</surname><given-names>C. D.</given-names></name></person-group> (<year>2015</year>). <article-title>Complete biosynthesis of opioids in yeast.</article-title>
<source><italic>Science</italic></source>
<volume>349</volume>
<fpage>1095</fpage>&#x02013;<lpage>1100</lpage>. <pub-id pub-id-type="doi">10.1126/science.aac9373</pub-id>
<?supplied-pmid 26272907?><pub-id pub-id-type="pmid">26272907</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerlt</surname><given-names>J. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Tools and strategies for discovering novel enzymes and metabolic pathways.</article-title>
<source><italic>Perspect. Sci.</italic></source> 9(Suppl. C), <fpage>24</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.pisc.2016.07.001</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerlt</surname><given-names>J. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Genomic enzymology: web tools for leveraging protein family sequence-function space and genome context to discover novel functions.</article-title>
<source><italic>Biochemistry</italic></source>
<volume>56</volume>
<fpage>4293</fpage>&#x02013;<lpage>4308</lpage>. <pub-id pub-id-type="doi">10.1021/acs.biochem.7b00614</pub-id>
<?supplied-pmid 28826221?><pub-id pub-id-type="pmid">28826221</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerlt</surname><given-names>J. A.</given-names></name><name><surname>Babbitt</surname><given-names>P. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Enzyme (re)design: lessons from natural evolution and computation.</article-title>
<source><italic>Curr. Opin. Chem. Biol.</italic></source>
<volume>13</volume>
<fpage>10</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2009.01.014</pub-id>
<?supplied-pmid 19237310?><pub-id pub-id-type="pmid">19237310</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>R. D.</given-names></name></person-group> (<year>2016</year>). <article-title>Recent advances in enzyme promiscuity.</article-title>
<source><italic>Sustain. Chem. Process.</italic></source>
<volume>4</volume>:<issue>2</issue>
<pub-id pub-id-type="doi">10.1186/s40508-016-0046-9</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartwell</surname><given-names>L. H.</given-names></name><name><surname>Hopfield</surname><given-names>J. J.</given-names></name><name><surname>Leibler</surname><given-names>S.</given-names></name><name><surname>Murray</surname><given-names>A. W.</given-names></name></person-group> (<year>1999</year>). <article-title>From molecular to modular cell biology.</article-title>
<source><italic>Nature</italic></source>
<volume>402(Suppl. 6761)</volume>, <fpage>C47</fpage>&#x02013;<lpage>C52</lpage>. <pub-id pub-id-type="doi">10.1038/35011540</pub-id>
<?supplied-pmid 10591225?><pub-id pub-id-type="pmid">10591225</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>A. L.</given-names></name></person-group> (<year>2008</year>). <article-title>Natural products in drug discovery.</article-title>
<source><italic>Drug Discov. Today</italic></source>
<volume>13</volume>
<fpage>894</fpage>&#x02013;<lpage>901</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2008.07.004</pub-id>
<?supplied-pmid 18691670?><pub-id pub-id-type="pmid">18691670</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakociunas</surname><given-names>T.</given-names></name><name><surname>Bonde</surname><given-names>I.</given-names></name><name><surname>Herrgard</surname><given-names>M.</given-names></name><name><surname>Harrison</surname><given-names>S. J.</given-names></name><name><surname>Kristensen</surname><given-names>M.</given-names></name><name><surname>Pedersen</surname><given-names>L. E.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Multiplex metabolic pathway engineering using CRISPR/Cas9 in <italic>Saccharomyces cerevisiae</italic>.</article-title>
<source><italic>Metab. Eng.</italic></source>
<volume>28</volume>
<fpage>213</fpage>&#x02013;<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymben.2015.01.008</pub-id>
<?supplied-pmid 25638686?><pub-id pub-id-type="pmid">25638686</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>M.</given-names></name><name><surname>Pfeifer</surname><given-names>B. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Metabolic and pathway engineering to influence native and altered erythromycin production through <italic>E. coli</italic>.</article-title>
<source><italic>Metab. Eng.</italic></source>
<volume>19</volume>
<fpage>42</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymben.2013.05.005</pub-id>
<?supplied-pmid 23747605?><pub-id pub-id-type="pmid">23747605</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Park</surname><given-names>S. H.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Pfeifer</surname><given-names>B. A.</given-names></name></person-group> (<year>2013</year>). <article-title>DeoxysugarI pathway interchange for erythromycin analogues heterologously produced through <italic>Escherichia coli</italic>.</article-title>
<source><italic>Metab. Eng.</italic></source>
<volume>20</volume>
<fpage>92</fpage>&#x02013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymben.2013.09.005</pub-id>
<?supplied-pmid 24060454?><pub-id pub-id-type="pmid">24060454</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Z.</given-names></name><name><surname>Wong</surname><given-names>A.</given-names></name><name><surname>Foo</surname><given-names>J. L.</given-names></name><name><surname>Ng</surname><given-names>J.</given-names></name><name><surname>Cao</surname><given-names>Y. X.</given-names></name><name><surname>Chang</surname><given-names>M. W.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Engineering <italic>Saccharomyces cerevisiae</italic> to produce odd chain-length fatty alcohols.</article-title>
<source><italic>Biotechnol. Bioeng.</italic></source>
<volume>113</volume>
<fpage>842</fpage>&#x02013;<lpage>851</lpage>. <pub-id pub-id-type="doi">10.1002/bit.25856</pub-id>
<?supplied-pmid 26461930?><pub-id pub-id-type="pmid">26461930</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kan</surname><given-names>S. B.</given-names></name><name><surname>Lewis</surname><given-names>R. D.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Arnold</surname><given-names>F. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Directed evolution of cytochrome c for carbon-silicon bond formation: bringing silicon to life.</article-title>
<source><italic>Science</italic></source>
<volume>354</volume>
<fpage>1048</fpage>&#x02013;<lpage>1051</lpage>. <pub-id pub-id-type="doi">10.1126/science.aah6219</pub-id>
<?supplied-pmid 27885032?><pub-id pub-id-type="pmid">27885032</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kan</surname><given-names>S. B. J.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Gumulya</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Arnold</surname><given-names>F. H.</given-names></name></person-group> (<year>2017</year>). <article-title>Genetically programmed chiral organoborane synthesis.</article-title>
<source><italic>Nature</italic></source>
<volume>552</volume>
<fpage>132</fpage>&#x02013;<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1038/nature24996</pub-id>
<?supplied-pmid 29186119?><pub-id pub-id-type="pmid">29186119</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khosla</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Quo vadis, enzymology?</article-title>
<source><italic>Nat. Chem. Biol.</italic></source>
<volume>11</volume>
<fpage>438</fpage>&#x02013;<lpage>441</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1844</pub-id>
<?supplied-pmid 26083060?><pub-id pub-id-type="pmid">26083060</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H. Y.</given-names></name><name><surname>Harvey</surname><given-names>C. J.</given-names></name><name><surname>Cane</surname><given-names>D. E.</given-names></name><name><surname>Khosla</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Improved precursor-directed biosynthesis in <italic>E. coli</italic> via directed evolution.</article-title>
<source><italic>J. Antibiot.</italic></source>
<volume>64</volume>
<fpage>59</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1038/ja.2010.129</pub-id>
<?supplied-pmid 21081955?><pub-id pub-id-type="pmid">21081955</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S. Y.</given-names></name><name><surname>Kim</surname><given-names>H. U.</given-names></name></person-group> (<year>2015</year>). <article-title>Systems strategies for developing industrial microbial strains.</article-title>
<source><italic>Nat. Biotechnol.</italic></source>
<volume>33</volume>
<fpage>1061</fpage>&#x02013;<lpage>1072</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.3365</pub-id>
<?supplied-pmid 26448090?><pub-id pub-id-type="pmid">26448090</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lid&#x000e9;n</surname><given-names>G.</given-names></name></person-group> (<year>2017</year>). <article-title>Carboxylic acid production.</article-title>
<source><italic>Fermentation</italic></source>
<volume>3</volume>:<issue>46</issue>
<pub-id pub-id-type="doi">10.3390/fermentation3030046</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maoka</surname><given-names>T.</given-names></name><name><surname>Takemura</surname><given-names>M.</given-names></name><name><surname>Tokuda</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>N.</given-names></name><name><surname>Misawa</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>4-Ketozeinoxanthin, a novel carotenoid produced in <italic>Escherichia coli</italic> through metabolic engineering using carotenogenic genes of bacterium and liverwort.</article-title>
<source><italic>Tetrahedron Lett.</italic></source>
<volume>55</volume>
<fpage>6708</fpage>&#x02013;<lpage>6710</lpage>. <pub-id pub-id-type="doi">10.1016/j.tetlet.2014.10.033</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medema</surname><given-names>M. H.</given-names></name><name><surname>Fischbach</surname><given-names>M. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Computational approaches to natural product discovery.</article-title>
<source><italic>Nat. Chem. Biol.</italic></source>
<volume>11</volume>
<fpage>639</fpage>&#x02013;<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1884</pub-id>
<?supplied-pmid 26284671?><pub-id pub-id-type="pmid">26284671</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menendez-Bravo</surname><given-names>S.</given-names></name><name><surname>Comba</surname><given-names>S.</given-names></name><name><surname>Sabatini</surname><given-names>M.</given-names></name><name><surname>Arabolaza</surname><given-names>A.</given-names></name><name><surname>Gramajo</surname><given-names>H.</given-names></name></person-group> (<year>2014</year>). <article-title>Expanding the chemical diversity of natural esters by engineering a polyketide-derived pathway into <italic>Escherichia coli</italic>.</article-title>
<source><italic>Metab. Eng.</italic></source>
<volume>24</volume>
<fpage>97</fpage>&#x02013;<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymben.2014.05.002</pub-id>
<?supplied-pmid 24831705?><pub-id pub-id-type="pmid">24831705</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morita</surname><given-names>H.</given-names></name><name><surname>Yamashita</surname><given-names>M.</given-names></name><name><surname>Shi</surname><given-names>S. P.</given-names></name><name><surname>Wakimoto</surname><given-names>T.</given-names></name><name><surname>Kondo</surname><given-names>S.</given-names></name><name><surname>Kato</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Synthesis of unnatural alkaloid scaffolds by exploiting plant polyketide synthase.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>108</volume>
<fpage>13504</fpage>&#x02013;<lpage>13509</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1107782108</pub-id>
<?supplied-pmid 21825160?><pub-id pub-id-type="pmid">21825160</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikel</surname><given-names>P. I.</given-names></name><name><surname>Martinez-Garcia</surname><given-names>E.</given-names></name><name><surname>de Lorenzo</surname><given-names>V.</given-names></name></person-group> (<year>2014</year>). <article-title>Biotechnological domestication of pseudomonads using synthetic biology.</article-title>
<source><italic>Nat. Rev. Microbiol.</italic></source>
<volume>12</volume>
<fpage>368</fpage>&#x02013;<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro3253</pub-id>
<?supplied-pmid 24736795?><pub-id pub-id-type="pmid">24736795</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oksman-Caldentey</surname><given-names>K. M.</given-names></name><name><surname>Inze</surname><given-names>D.</given-names></name></person-group> (<year>2004</year>). <article-title>Plant cell factories in the post-genomic era: new ways to produce designer secondary metabolites.</article-title>
<source><italic>Trends Plant Sci.</italic></source>
<volume>9</volume>
<fpage>433</fpage>&#x02013;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1016/j.tplants.2004.07.006</pub-id>
<?supplied-pmid 15337493?><pub-id pub-id-type="pmid">15337493</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oyetunde</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>M. H.</given-names></name><name><surname>Chen</surname><given-names>Y. X.</given-names></name><name><surname>Tang</surname><given-names>Y. J.</given-names></name><name><surname>Lo</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>BoostGAPFILL: improving the fidelity of metabolic network reconstructions through integrated constraint and pattern-based methods.</article-title>
<source><italic>Bioinformatics</italic></source>
<volume>33</volume>
<fpage>608</fpage>&#x02013;<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btw684</pub-id>
<?supplied-pmid 27797784?><pub-id pub-id-type="pmid">27797784</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pham</surname><given-names>H. L.</given-names></name><name><surname>Wong</surname><given-names>A.</given-names></name><name><surname>Chua</surname><given-names>N.</given-names></name><name><surname>Teo</surname><given-names>W. S.</given-names></name><name><surname>Yew</surname><given-names>W. S.</given-names></name><name><surname>Chang</surname><given-names>M. W.</given-names></name></person-group> (<year>2017</year>). <article-title>Engineering a riboswitch-based genetic platform for the self-directed evolution of acid-tolerant phenotypes.</article-title>
<source><italic>Nat. Commun.</italic></source>
<volume>8</volume>:<issue>411</issue>. <pub-id pub-id-type="doi">10.1038/s41467-017-00511-w</pub-id>
<?supplied-pmid 28871084?><pub-id pub-id-type="pmid">28871084</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proschel</surname><given-names>M.</given-names></name><name><surname>Detsch</surname><given-names>R.</given-names></name><name><surname>Boccaccini</surname><given-names>A. R.</given-names></name><name><surname>Sonnewald</surname><given-names>U.</given-names></name></person-group> (<year>2015</year>). <article-title>Engineering of metabolic pathways by artificial enzyme channels.</article-title>
<source><italic>Front. Bioeng. Biotechnol.</italic></source>
<volume>3</volume>:<issue>168</issue>. <pub-id pub-id-type="doi">10.3389/fbioe.2015.00168</pub-id>
<?supplied-pmid 26557643?><pub-id pub-id-type="pmid">26557643</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Yuan</surname><given-names>Q.</given-names></name><name><surname>Yan</surname><given-names>Y.</given-names></name></person-group> (<year>2017</year>). <article-title>High-level De novo biosynthesis of arbutin in engineered <italic>Escherichia coli</italic>.</article-title>
<source><italic>Metab. Eng.</italic></source>
<volume>42</volume>
<fpage>52</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymben.2017.06.001</pub-id>
<?supplied-pmid 28583673?><pub-id pub-id-type="pmid">28583673</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>H. U.</given-names></name><name><surname>Kim</surname><given-names>D. I.</given-names></name><name><surname>Lee</surname><given-names>S. Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Production of bulk chemicals via novel metabolic pathways in microorganisms.</article-title>
<source><italic>Biotechnol. Adv.</italic></source>
<volume>31</volume>
<fpage>925</fpage>&#x02013;<lpage>935</lpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2012.12.008</pub-id>
<?supplied-pmid 23280013?><pub-id pub-id-type="pmid">23280013</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>J.-W.</given-names></name><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Bornscheuer</surname><given-names>U. T.</given-names></name><name><surname>Park</surname><given-names>J.-B.</given-names></name></person-group> (<year>2014</year>). <article-title>Microbial synthesis of medium-chain &#x003b1;,&#x003c9;-dicarboxylic acids and &#x003c9;-aminocarboxylic acids from renewable long-chain fatty acids.</article-title>
<source><italic>Adv. Synth. Catal.</italic></source>
<volume>356</volume>
<fpage>1782</fpage>&#x02013;<lpage>1788</lpage>. <pub-id pub-id-type="doi">10.1002/adsc.201300784</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugimoto</surname><given-names>Y.</given-names></name><name><surname>Ding</surname><given-names>L.</given-names></name><name><surname>Ishida</surname><given-names>K.</given-names></name><name><surname>Hertweck</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Rational design of modular polyketide synthases: morphing the aureothin pathway into a luteoreticulin assembly line.</article-title>
<source><italic>Angew. Chem. Int. Ed. Engl.</italic></source>
<volume>53</volume>
<fpage>1560</fpage>&#x02013;<lpage>1564</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201308176</pub-id>
<?supplied-pmid 24402879?><pub-id pub-id-type="pmid">24402879</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiele</surname><given-names>I.</given-names></name><name><surname>Vlassis</surname><given-names>N.</given-names></name><name><surname>Fleming</surname><given-names>R. M.</given-names></name></person-group> (<year>2014</year>). <article-title>fastGapFill: efficient gap filling in metabolic networks.</article-title>
<source><italic>Bioinformatics</italic></source>
<volume>30</volume>
<fpage>2529</fpage>&#x02013;<lpage>2531</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu321</pub-id>
<?supplied-pmid 24812336?><pub-id pub-id-type="pmid">24812336</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thirlway</surname><given-names>J.</given-names></name><name><surname>Lewis</surname><given-names>R.</given-names></name><name><surname>Nunns</surname><given-names>L.</given-names></name><name><surname>Al Nakeeb</surname><given-names>M.</given-names></name><name><surname>Styles</surname><given-names>M.</given-names></name><name><surname>Struck</surname><given-names>A. W.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Introduction of a non-natural amino acid into a nonribosomal peptide antibiotic by modification of adenylation domain specificity.</article-title>
<source><italic>Angew. Chem. Int. Ed. Engl.</italic></source>
<volume>51</volume>
<fpage>7181</fpage>&#x02013;<lpage>7184</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201202043</pub-id>
<?supplied-pmid 22711659?><pub-id pub-id-type="pmid">22711659</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>M. C.</given-names></name><name><surname>Thuronyi</surname><given-names>B. W.</given-names></name><name><surname>Charkoudian</surname><given-names>L. K.</given-names></name><name><surname>Lowry</surname><given-names>B.</given-names></name><name><surname>Khosla</surname><given-names>C.</given-names></name><name><surname>Chang</surname><given-names>M. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Expanding the fluorine chemistry of living systems using engineered polyketide synthase pathways.</article-title>
<source><italic>Science</italic></source>
<volume>341</volume>
<fpage>1089</fpage>&#x02013;<lpage>1094</lpage>. <pub-id pub-id-type="doi">10.1126/science.1242345</pub-id>
<?supplied-pmid 24009388?><pub-id pub-id-type="pmid">24009388</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>S.</given-names></name><name><surname>Balskus</surname><given-names>E. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Opportunities for merging chemical and biological synthesis.</article-title>
<source><italic>Curr. Opin. Biotechnol.</italic></source>
<volume>30</volume>
<fpage>1</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2014.03.006</pub-id>
<?supplied-pmid 24747284?><pub-id pub-id-type="pmid">24747284</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walther</surname><given-names>T.</given-names></name><name><surname>Topham</surname><given-names>C. M.</given-names></name><name><surname>Irague</surname><given-names>R.</given-names></name><name><surname>Auriol</surname><given-names>C.</given-names></name><name><surname>Baylac</surname><given-names>A.</given-names></name><name><surname>Cordier</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor 2,4-dihydroxybutyric acid.</article-title>
<source><italic>Nat. Commun.</italic></source>
<volume>8</volume>:<issue>15828</issue>. <pub-id pub-id-type="doi">10.1038/ncomms15828</pub-id>
<?supplied-pmid 28631755?><pub-id pub-id-type="pmid">28631755</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Kim</surname><given-names>W.</given-names></name><name><surname>Pickens</surname><given-names>L. B.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Heterologous expression and manipulation of three tetracycline biosynthetic pathways.</article-title>
<source><italic>Angew. Chem. Int. Ed. Engl.</italic></source>
<volume>51</volume>
<fpage>11136</fpage>&#x02013;<lpage>11140</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201205426</pub-id>
<?supplied-pmid 23024027?><pub-id pub-id-type="pmid">23024027</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Ingram</surname><given-names>L. O.</given-names></name><name><surname>Shanmugam</surname><given-names>K. T.</given-names></name></person-group> (<year>2011</year>). <article-title>Evolution of D-lactate dehydrogenase activity from glycerol dehydrogenase and its utility for D-lactate production from lignocellulose.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>108</volume>
<fpage>18920</fpage>&#x02013;<lpage>18925</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1111085108</pub-id>
<?supplied-pmid 22065761?><pub-id pub-id-type="pmid">22065761</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Xiao</surname><given-names>A.</given-names></name><name><surname>Rasmussen</surname><given-names>M.</given-names></name><name><surname>Skidmore</surname><given-names>C.</given-names></name><name><surname>Zhan</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Metabolic engineering of <italic>Escherichia coli</italic> for the biosynthesis of various phenylpropanoid derivatives.</article-title>
<source><italic>Metab. Eng.</italic></source>
<volume>29</volume>
<fpage>153</fpage>&#x02013;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymben.2015.03.011</pub-id>
<?supplied-pmid 25819309?><pub-id pub-id-type="pmid">25819309</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>M. C.</given-names></name><name><surname>Moore</surname><given-names>B. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Beyond ethylmalonyl-CoA: the functional role of crotonyl-CoA carboxylase/reductase homologs in expanding polyketide diversity.</article-title>
<source><italic>Nat. Prod. Rep.</italic></source>
<volume>29</volume>
<fpage>72</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1039/c1np00082a</pub-id>
<?supplied-pmid 22124767?><pub-id pub-id-type="pmid">22124767</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>G.</given-names></name><name><surname>Yan</surname><given-names>Q.</given-names></name><name><surname>Jones</surname><given-names>J. A.</given-names></name><name><surname>Tang</surname><given-names>Y. J.</given-names></name><name><surname>Fong</surname><given-names>S. S.</given-names></name><name><surname>Koffas</surname><given-names>M. A. G.</given-names></name></person-group> (<year>2016</year>). <article-title>Metabolic burden: cornerstones in synthetic biology and metabolic engineering applications.</article-title>
<source><italic>Trends Biotechnol.</italic></source>
<volume>34</volume>
<fpage>652</fpage>&#x02013;<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2016.02.010</pub-id>
<?supplied-pmid 26996613?><pub-id pub-id-type="pmid">26996613</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S. G.</given-names></name><name><surname>Shimizu</surname><given-names>K.</given-names></name><name><surname>Tang</surname><given-names>J. K.-H.</given-names></name><name><surname>Tang</surname><given-names>Y. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Facilitate collaborations among synthetic biology. Metabolic engineering and machine learning.</article-title>
<source><italic>ChemBioEng Rev.</italic></source>
<volume>3</volume>
<fpage>45</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1002/cben.201500024</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Chaiprasongsuk</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>N.</given-names></name><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Substrate-assisted catalysis in the reaction catalyzed by salicylic acid binding protein 2 (SABP2), a potential mechanism of substrate discrimination for some promiscuous enzymes.</article-title>
<source><italic>Biochemistry</italic></source>
<volume>54</volume>
<fpage>5366</fpage>&#x02013;<lpage>5375</lpage>. <pub-id pub-id-type="doi">10.1021/acs.biochem.5b00638</pub-id>
<?supplied-pmid 26244568?><pub-id pub-id-type="pmid">26244568</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Y. F.</given-names></name><name><surname>Wang</surname><given-names>C. S.</given-names></name><name><surname>Qiao</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>G. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Metabolic engineering of <italic>Escherichia coli</italic> for production of salvianic acid A via an artificial biosynthetic pathway.</article-title>
<source><italic>Metab. Eng.</italic></source>
<volume>19</volume>
<fpage>79</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymben.2013.06.001</pub-id>
<?supplied-pmid 23774671?><pub-id pub-id-type="pmid">23774671</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Plan</surname><given-names>M. R.</given-names></name><name><surname>Winter</surname><given-names>G.</given-names></name><name><surname>Kromer</surname><given-names>J. O.</given-names></name></person-group> (<year>2016</year>). <article-title>Metabolic Engineering of <italic>Pseudomonas putida</italic> KT2440 for the Production of para-Hydroxy Benzoic Acid.</article-title>
<source><italic>Front. Bioeng. Biotechnol.</italic></source>
<volume>4</volume>:<issue>90</issue>. <pub-id pub-id-type="doi">10.3389/fbioe.2016.00090</pub-id>
<?supplied-pmid 27965953?><pub-id pub-id-type="pmid">27965953</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Skalina</surname><given-names>K.</given-names></name><name><surname>Pfeifer</surname><given-names>B. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Complete biosynthesis of erythromycin A and designed analogs using <italic>E. coli</italic> as a heterologous host.</article-title>
<source><italic>Chem. Biol.</italic></source>
<volume>17</volume>
<fpage>1232</fpage>&#x02013;<lpage>1240</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2010.09.013</pub-id>
<?supplied-pmid 21095573?><pub-id pub-id-type="pmid">21095573</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Kao</surname><given-names>E.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Baidoo</surname><given-names>E. E. K.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Keasling</surname><given-names>J. D.</given-names></name></person-group> (<year>2016</year>). <article-title>Metabolic engineering of <italic>Escherichia coli</italic> for the biosynthesis of 2-pyrrolidone.</article-title>
<source><italic>Metab. Eng. Commun.</italic></source> 3(Suppl. C), <fpage>1</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.meteno.2015.11.001</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Ptacin</surname><given-names>J. L.</given-names></name><name><surname>Fischer</surname><given-names>E. C.</given-names></name><name><surname>Aerni</surname><given-names>H. R.</given-names></name><name><surname>Caffaro</surname><given-names>C. E.</given-names></name><name><surname>San Jose</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>A semi-synthetic organism that stores and retrieves increased genetic information.</article-title>
<source><italic>Nature</italic></source>
<volume>551</volume>
<fpage>644</fpage>&#x02013;<lpage>647</lpage>. <pub-id pub-id-type="doi">10.1038/nature24659</pub-id>
<?supplied-pmid 29189780?><pub-id pub-id-type="pmid">29189780</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Q.</given-names></name><name><surname>Jackson</surname><given-names>E. N.</given-names></name></person-group> (<year>2015</year>). <article-title>Metabolic engineering of <italic>Yarrowia lipolytica</italic> for industrial applications.</article-title>
<source><italic>Curr. Opin. Biotechnol.</italic></source>
<volume>36</volume>
<fpage>65</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2015.08.010</pub-id>
<?supplied-pmid 26319895?><pub-id pub-id-type="pmid">26319895</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name></person-group> (<year>2015</year>). <article-title>De novo biosynthesis of terminal alkyne-labeled natural products.</article-title>
<source><italic>Nat. Chem. Biol.</italic></source>
<volume>11</volume>
<fpage>115</fpage>&#x02013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1718</pub-id>
<?supplied-pmid 25531891?><pub-id pub-id-type="pmid">25531891</pub-id></mixed-citation></ref></ref-list></back></article>